Stéphane Bancel, Moderna CEO (Christopher Goodney/Bloomberg via Getty Images)
Moderna spells out rare disease ambitions: 'We have a bunch of INDs planned'
Moderna said in June that it was “quadrupling down” on rare disease. Right now, that looks like nine or so INDs in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
